
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MUC1 induces the accumulation of Foxp3+ Treg cells in the tumor microenvironment to promote the growth and metastasis of cholangiocarcinoma through the EGFR/PI3K/Akt signaling pathway
Guofeng Zhang, Zheng Ge, Haipeng Zhang, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110091-110091
Closed Access | Times Cited: 12
Guofeng Zhang, Zheng Ge, Haipeng Zhang, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110091-110091
Closed Access | Times Cited: 12
Showing 12 citing articles:
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 28
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 28
MUC1 and MUC16: critical for immune modulation in cancer therapeutics
Xinyi Chen, Ineza Karambizi Sandrine, Mu Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Xinyi Chen, Ineza Karambizi Sandrine, Mu Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Tumor-infiltrating T lymphocytes: A promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma
Sijia Hua, Xinyi Gu, Hangbin Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117080-117080
Open Access | Times Cited: 7
Sijia Hua, Xinyi Gu, Hangbin Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117080-117080
Open Access | Times Cited: 7
Crosstalk of pyroptosis and cytokine in the tumor microenvironment: from mechanisms to clinical implication
Hua Wang, Tao Wang, Shuxiang Yan, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Hua Wang, Tao Wang, Shuxiang Yan, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell Therapy
Neda Dadgar, Arun Kumar Arunachalam, Hanna Hong, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3232-3232
Open Access | Times Cited: 4
Neda Dadgar, Arun Kumar Arunachalam, Hanna Hong, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3232-3232
Open Access | Times Cited: 4
Proximity Labeling: Precise Proteomics Technology for Mapping Receptor Protein Neighborhoods at the Cancer Cell Surface
Saman Rahmati, Andrew Emili
Cancers (2025) Vol. 17, Iss. 2, pp. 179-179
Open Access
Saman Rahmati, Andrew Emili
Cancers (2025) Vol. 17, Iss. 2, pp. 179-179
Open Access
Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
Yunyan Dai, Chenyang Dong, Zhiming Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Yunyan Dai, Chenyang Dong, Zhiming Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
The Immune–Genomics of Cholangiocarcinoma: A Biological Footprint to Develop Novel Immunotherapies
Antonella Cammarota, Rita Balsano, Tiziana Pressiani, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 272-272
Open Access
Antonella Cammarota, Rita Balsano, Tiziana Pressiani, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 272-272
Open Access
Research progress of T cells in cholangiocarcinoma
Zhiming Wang, Yunyan Dai, Yunpeng Zhou, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Zhiming Wang, Yunyan Dai, Yunpeng Zhou, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review)
Siqi Yang, Rui-Qi Zou, Yu-Shi Dai, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 6
Open Access | Times Cited: 7
Siqi Yang, Rui-Qi Zou, Yu-Shi Dai, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 6
Open Access | Times Cited: 7
Immune cells mediate the causal pathway linking circulating complements to cancer: A Mendelian randomization study
Hao Pan, Changqing Jing
Inflammation Research (2024) Vol. 73, Iss. 12, pp. 2141-2152
Closed Access
Hao Pan, Changqing Jing
Inflammation Research (2024) Vol. 73, Iss. 12, pp. 2141-2152
Closed Access
Therapeutic significance of tumor microenvironment in cholangiocarcinoma: focus on tumor-infiltrating T lymphocytes
Chaoqun Li, Lei Bie, Muhua Chen, et al.
Exploration of Targeted Anti-tumor Therapy (2023) Vol. 4, Iss. 6, pp. 1310-1327
Open Access | Times Cited: 1
Chaoqun Li, Lei Bie, Muhua Chen, et al.
Exploration of Targeted Anti-tumor Therapy (2023) Vol. 4, Iss. 6, pp. 1310-1327
Open Access | Times Cited: 1